DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "13th Annual Report and Survey Biopharmaceutical Manufacturing Capacity and Production" report to their offering. This report's 492 pages of d... Read more
Pharmacy
- LIU Pharmacy Joins the National Institute for Pharmaceutical Technology and Education (NIPTE)
- Nuclear Medicine Patent Overview 2011-2016 – Research and Markets
- ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer
- Exelixis Announces Redemption of All Remaining 4.25% Convertible Senior Subordinated Notes Due 2019
- Cardax Launches First Product ZanthoSyn™
- Inotek Pharmaceuticals Announces the Completion of the Recruitment Phase of MATrX-1, the First Phase 3 Clinical Trial of Trabodenoson for Glaucoma
Clinical Trials
- Includes Clinical Data from the Phase 2a Influenza Virus Challenge Study of VIS410 and Preclinical Data that Demonstrated VIS410 Does Not Cause Antibody-Dependent Enhancement - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc., a clinical-stage biotechnology company,... Read more
- Biothera Pharmaceuticals Expands Relationship with Merck, Enters Collaboration for Combination Cancer Immunotherapy Trials in Multiple Indications
- SAB Biotherapeutics Announces Contract with BARDA to Advance First MERS Treatment
- SAB Biotherapeutics Announces Contract with BARDA to Advance First MERS Treatment
- Rosetta Genomics Selected by a Global Pharmaceutical Company to Supply FISH Testing Services for Clinical Study in Prostate Cancer
- Inotek Pharmaceuticals Announces the Completion of the Recruitment Phase of MATrX-1, the First Phase 3 Clinical Trial of Trabodenoson for Glaucoma
- Pancreatic Beta-Cell Protection Market 2016 – Hot Targets & Pipeline Analysis Report – Research and Markets
Infectious Disease
Funding for therapeutic manufacturing and testing from rapid response platform SIOUX FALLS, S.D.--(BUSINESS WIRE)--SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical development company, announced today that it has been awarded a contract for up to $5.3... Read more
- Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca
- GCC Countries Anti-Viral Drugs Market Outlook (2016-2021) – Key Players are Abbott, Gilead & GlaxoSmithKline – Research and Markets
- CEL-SCI Announces $5 Million Registered Direct Offering
- Oragenics Selects New Lantibiotic for Further Development in Clostridium difficile Infections
- PSI Shares Insights Into Microbiology Data Review
- Zalgen Labs Introduces Viral Diagnostics Business, Opens Advanced Product Development Center in Colorado
